{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T03:46:29Z","timestamp":1794714389162,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,8,15]],"date-time":"2014-08-15T00:00:00Z","timestamp":1408060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1245\/s10434-014-3978-x","type":"journal-article","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T17:42:00Z","timestamp":1408038120000},"page":"1686-1693","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":208,"title":["Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: A Systematic Review and Meta-analysis"],"prefix":"10.1245","volume":"22","author":[{"given":"Joseph H.","family":"Helm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Glenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca K.","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Larrieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thejus T.","family":"Jayakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E.","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Clark","family":"Gamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran K.","family":"Turaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian M.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,15]]},"reference":[{"key":"3978_CR1","first-page":"32","volume":"9","author":"A Bridda","year":"2007","unstructured":"Bridda A, Padoan I, Mencarelli R, Frego M. Peritoneal mesothelioma: a review. Med Gen Med. 2007; 9:32.","journal-title":"MedGenMed."},{"key":"3978_CR2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/annonc\/mdl428","volume":"18","author":"TD Yan","year":"2007","unstructured":"Yan TD, Welch L, Black D, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol. 2007; 18:827\u201334.","journal-title":"Ann Oncol."},{"key":"3978_CR3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/annonc\/mdl345","volume":"18","author":"P Boffetta","year":"2007","unstructured":"Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007; 18:985\u201390.","journal-title":"Ann Oncol."},{"key":"3978_CR4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jso.21177","volume":"99","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Morris DL. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience. J Surg Oncol. 2009; 99:109\u201313.","journal-title":"J Surg Oncol."},{"key":"3978_CR5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3816\/CLC.2005.n.020","volume":"7","author":"PA Janne","year":"2005","unstructured":"Janne PA, Wozniak AJ, Belani CP, et al. Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program. Clin Lung Cancer. 2005; 7:40\u20136.","journal-title":"Clin Lung Cancer."},{"key":"3978_CR6","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1200\/JCO.2007.15.2868","volume":"26","author":"GR Simon","year":"2008","unstructured":"Simon GR, Verschraegen CF, Janne PA, et al. Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial. J Clin Oncol. 2008; 26:3567\u201372.","journal-title":"J Clin Oncol."},{"key":"3978_CR7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.lungcan.2008.08.013","volume":"64","author":"G Carteni","year":"2009","unstructured":"Carteni G, Manegold C, Garcia GM, et al. Malignant peritoneal mesothelioma: results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent. Lung Cancer. 2009; 64:211\u20138.","journal-title":"Lung Cancer."},{"key":"3978_CR8","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1081\/CNV-120023766","volume":"21","author":"DT Le","year":"2003","unstructured":"Le DT, Deavers M, Hunt K, Malpica A, Verschraegen CF. Cisplatin and irinotecan (CPT-11) for peritoneal mesothelioma. Cancer Invest. 2003; 21:682\u20139.","journal-title":"Cancer Invest."},{"issue":"4","key":"3978_CR9","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1245\/s10434-013-3358-y","volume":"21","author":"D Magge","year":"2013","unstructured":"Magge D, Zenati MS, Austin F, et al. Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis. Ann Surg Oncol. 2013; 21(4):1159\u201365.","journal-title":"Ann Surg Oncol."},{"key":"3978_CR10","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0399-8320(07)73964-7","volume":"31","author":"D Elias","year":"2007","unstructured":"Elias D, Bedard V, Bouzid T, et al. Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy. Gastroenterol Clin Biol. 2007; 31:784\u20138.","journal-title":"Gastroenterol Clin Biol."},{"key":"3978_CR11","doi-asserted-by":"crossref","unstructured":"Sugarbaker PH, Welch LS, Mohamed F, Glehen O. A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin N Am. 2003; 12:605\u201321, xi.","DOI":"10.1016\/S1055-3207(03)00045-0"},{"key":"3978_CR12","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283:2008\u201312.","journal-title":"JAMA."},{"key":"3978_CR13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995; 221:29\u201342.","journal-title":"Ann Surg."},{"key":"3978_CR14","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0002-9343(82)90787-2","volume":"73","author":"JR Beck","year":"1982","unstructured":"Beck JR, Pauker SG, Gottlieb JE, Klein K, Kassirer JP. A convenient approximation of life expectancy (the \u201cDEALE\u201d). II: use in medical decision-making. Am J Med. 1982; 73:889\u201397.","journal-title":"Am J Med."},{"key":"3978_CR15","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6:e1000097.","journal-title":"PLoS Med."},{"key":"3978_CR16","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009; 27:6237\u201342.","journal-title":"J Clin Oncol."},{"key":"3978_CR17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1245\/s10434-012-2845-x","volume":"20","author":"M Deraco","year":"2013","unstructured":"Deraco M, Baratti D, Hutanu I, Bertuli R, Kusamura S. The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2013; 20:1093\u2013100.","journal-title":"Ann Surg Oncol."},{"key":"3978_CR18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1245\/s10434-012-2651-5","volume":"20","author":"NP Schaub","year":"2013","unstructured":"Schaub NP, Alimchandani M, Quezado M, et al. A novel nomogram for peritoneal mesothelioma predicts survival. Ann Surg Oncol. 2013; 20:555\u201361.","journal-title":"Ann Surg Oncol."},{"key":"3978_CR19","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1245\/s10434-007-9475-8","volume":"14","author":"D Baratti","year":"2007","unstructured":"Baratti D, Kusamura S, Nonaka D, Oliva GD, Laterza B, Deraco M. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC). Ann Surg Oncol. 2007; 14:2790\u20137.","journal-title":"Ann Surg Oncol."},{"key":"3978_CR20","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ejso.2010.08.130","volume":"36","author":"D Baratti","year":"2010","unstructured":"Baratti D, Vaira M, Kusamura S, et al. Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Eur J Surg Oncol. 2010; 36:1047\u201353.","journal-title":"Eur J Surg Oncol."},{"key":"3978_CR21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1245\/ASO.2006.05.041","volume":"13","author":"C Brigand","year":"2006","unstructured":"Brigand C, Monneuse O, Mohamed F, et al. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study. Ann Surg Oncol. 2006; 13:405\u201312.","journal-title":"Ann Surg Oncol."},{"key":"3978_CR22","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/000313480106701019","volume":"67","author":"BW Loggie","year":"2001","unstructured":"Loggie BW, Fleming RA, McQuellon RP, Russell GB, Geisinger KR, Levine EA. Prospective trial for the treatment of malignant peritoneal mesothelioma. Am Surg. 2001; 67:999\u20131003.","journal-title":"Am Surg"},{"key":"3978_CR23","first-page":"174","volume":"3","author":"GY Ma","year":"1997","unstructured":"Ma GY, Bartlett DL, Reed E, et al. Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma. Cancer J Sci Am. 1997; 3:174\u20139.","journal-title":"Cancer J Sci Am."},{"key":"3978_CR24","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1046\/j.1365-2168.2000.01571.x","volume":"87","author":"G Sebbag","year":"2000","unstructured":"Sebbag G, Yan H, Shmookler BM, Chang D, Sugarbaker PH. Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg. 2000; 87:1587\u201393.","journal-title":"Br J Surg."},{"key":"3978_CR25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF01225271","volume":"118","author":"M Markman","year":"1992","unstructured":"Markman M, Kelsen D. Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma. J Cancer Res Clin Oncol. 1992; 118:547\u201350.","journal-title":"J Cancer Res Clin Oncol."},{"key":"3978_CR26","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1200\/JCO.2003.04.150","volume":"21","author":"AL Feldman","year":"2003","unstructured":"Feldman AL, Libutti SK, Pingpank JF, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol. 2003; 21:4560\u20137.","journal-title":"J Clin Oncol."},{"key":"3978_CR27","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.ejso.2008.09.010","volume":"35","author":"H Yano","year":"2009","unstructured":"Yano H, Moran BJ, Cecil TD, Murphy EM. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma. Eur J Surg Oncol. 2009; 35:980\u20135.","journal-title":"Eur J Surg Oncol."},{"key":"3978_CR28","first-page":"2416","volume":"39","author":"Y Yonemura","year":"2012","unstructured":"Yonemura Y, Ishibashi H, Canbay E, et al. Treatment results of diffuse malignant peritoneal mesothelioma. Gan To Kagaku Ryoho. 2012; 39:2416\u20139.","journal-title":"Gan To Kagaku Ryoho."},{"key":"3978_CR29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/000313481007600418","volume":"76","author":"EC Tudor","year":"2010","unstructured":"Tudor EC, Chua TC, Liauw W, Morris DL. Risk factors and clinicopathological study of prognostic factors in the peritoneal mesothelioma. Am Surg. 2010; 76:400\u20135.","journal-title":"Am Surg."},{"key":"3978_CR30","first-page":"41","volume":"22","author":"M Deraco","year":"2003","unstructured":"Deraco M, De Simone M, Rossi CR, et al. An Italian multicentric phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with peritoneal mesothelioma. J Exp Clin Cancer Res. 2003; 22:41\u20135.","journal-title":"J Exp Clin Cancer Res."},{"key":"3978_CR31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5152\/jtgga.2011.24","volume":"12","author":"R Macuks","year":"2011","unstructured":"Macuks R, Ozdemir H, Dursun P, Ozen OI, Haberal N, Ayhan A. Malignant intraperitoneal mesothelioma-Baskent University experience. J Turk Ger Gynecol Assoc. 2011; 12:104\u20139.","journal-title":"J Turk Ger Gynecol Assoc."},{"key":"3978_CR32","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1245\/s10434-010-1080-6","volume":"17","author":"AU Blackham","year":"2010","unstructured":"Blackham AU, Shen P, Stewart JH, Russell GB, Levine EA. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma: mitomycin versus cisplatin. Ann Surg Oncol. 2010; 17:2720\u20137.","journal-title":"Ann Surg Oncol."},{"key":"3978_CR33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/bjs.7263","volume":"98","author":"TC Chua","year":"2011","unstructured":"Chua TC, Yan TD, Deraco M, et al. Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma. Br J Surg. 2011;98:60-4.","journal-title":"Br J Surg."},{"key":"3978_CR34","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/jso.21787","volume":"103","author":"D Baratti","year":"2011","unstructured":"Baratti D, Kusamura S, Deraco M. Diffuse malignant peritoneal mesothelioma: systematic review of clinical management and biological research. J Surg Oncol. 2011; 103:822\u201331.","journal-title":"J Surg Oncol."},{"key":"3978_CR35","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jamcollsurg.2011.07.019","volume":"213","author":"SM Strasberg","year":"2011","unstructured":"Strasberg SM, Hall BL. Postoperative morbidity index: a quantitative measure of severity of postoperative complications. J Am Coll Surg. 2011; 213:616\u201326.","journal-title":"J Am Coll Surg."},{"key":"3978_CR36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ctrv.2011.10.006","volume":"38","author":"P Mirarabshahii","year":"2012","unstructured":"Mirarabshahii P, Pillai K, Chua TC, Pourgholami MH, Morris DL. Diffuse malignant peritoneal mesothelioma: an update on treatment. Cancer Treat Rev. 2012; 38:605\u201312.","journal-title":"Cancer Treat Rev."},{"key":"3978_CR37","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/cncr.25640","volume":"117","author":"TD Yan","year":"2011","unstructured":"Yan TD, Deraco M, Elias D, et al. A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database*. Cancer. 2011; 117:1855\u201363.","journal-title":"Cancer."},{"key":"3978_CR38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1245\/ASO.2006.03.045","volume":"13","author":"M Deraco","year":"2006","unstructured":"Deraco M, Nonaka D, Baratti D, et al. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol. 2006; 13:229\u201337.","journal-title":"Ann Surg Oncol."},{"key":"3978_CR39","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/aje\/kwt010","volume":"178","author":"D Madigan","year":"2013","unstructured":"Madigan D, Ryan PB, Schuemie M, et al. Evaluating the impact of database heterogeneity on observational study results. Am J Epidemiol. 2013; 178:645\u201351.","journal-title":"Am J Epidemiol."},{"key":"3978_CR40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-7622-2-8","volume":"2","author":"A Hartz","year":"2005","unstructured":"Hartz A, Bentler S, Charlton M, et al. Assessing observational studies of medical treatments. Emerg Themes Epidemiol. 2005; 2:8.","journal-title":"Emerg Themes Epidemiol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-3978-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-3978-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-3978-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T23:20:42Z","timestamp":1689463242000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-3978-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,15]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["3978"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-3978-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,15]]}}}